The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 07, 2017
Filed:
Jul. 27, 2015
Applicant:
Oncotherapy Science, Inc., Kanagawa, JP;
Inventors:
Yusuke Nakamura, Tokyo, JP;
Takuya Tsunoda, Kanagawa, JP;
Ryuji Osawa, Kanagawa, JP;
Sachiko Yoshimura, Kanagawa, JP;
Tomohisa Watanabe, Kanagawa, JP;
Gaku Nakayama, Kanagawa, JP;
Assignee:
OncoTherapy Science, Inc., Kanagawa, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 39/00 (2006.01); C07K 14/705 (2006.01); G01N 33/574 (2006.01); C07K 7/06 (2006.01); C12N 5/0783 (2010.01);
U.S. Cl.
CPC ...
A61K 39/0011 (2013.01); C07K 7/06 (2013.01); C07K 14/705 (2013.01); C12N 5/0638 (2013.01); G01N 33/57407 (2013.01); A61K 38/00 (2013.01); A61K 39/00 (2013.01); A61K 2039/5154 (2013.01); A61K 2039/5158 (2013.01); A61K 2039/53 (2013.01); C12N 2501/998 (2013.01); C12N 2502/1114 (2013.01);
Abstract
The present invention provides isolated peptides or the fragments derived from SEQ ID NO: 42, which bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL). The peptides may include one of the above mentioned amino acid sequences with substitution, deletion, or addition of one, two, or several amino acids sequences. The present invention also provides pharmaceutical compositions including these peptides. The peptides of this invention can be used for treating cancer.